MA26784A1 - Nouveau produit pharmaceutique. - Google Patents

Nouveau produit pharmaceutique.

Info

Publication number
MA26784A1
MA26784A1 MA26370A MA26370A MA26784A1 MA 26784 A1 MA26784 A1 MA 26784A1 MA 26370 A MA26370 A MA 26370A MA 26370 A MA26370 A MA 26370A MA 26784 A1 MA26784 A1 MA 26784A1
Authority
MA
Morocco
Prior art keywords
pharmaceutical product
new pharmaceutical
new
product
pharmaceutical
Prior art date
Application number
MA26370A
Other languages
English (en)
Inventor
Paul David Blackler
Robert Gordon Giles
Michael John Sasse
Andrew Simon Craig
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MA26784A1 publication Critical patent/MA26784A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA26370A 1999-04-20 2001-10-19 Nouveau produit pharmaceutique. MA26784A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9909075.5A GB9909075D0 (en) 1999-04-20 1999-04-20 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
MA26784A1 true MA26784A1 (fr) 2004-12-20

Family

ID=10851922

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26370A MA26784A1 (fr) 1999-04-20 2001-10-19 Nouveau produit pharmaceutique.

Country Status (42)

Country Link
EP (2) EP1173437B1 (fr)
JP (2) JP4283450B2 (fr)
KR (1) KR100677815B1 (fr)
CN (2) CN1327446A (fr)
AP (1) AP1680A (fr)
AR (2) AR023563A1 (fr)
AT (1) ATE262524T1 (fr)
AU (1) AU773112B2 (fr)
BG (1) BG65428B1 (fr)
BR (1) BR0009898A (fr)
CA (1) CA2370270A1 (fr)
CO (1) CO5170420A1 (fr)
CZ (1) CZ300934B6 (fr)
DE (1) DE60009276T2 (fr)
DK (1) DK1173437T3 (fr)
DZ (1) DZ3163A1 (fr)
EA (1) EA004769B1 (fr)
EG (1) EG23946A (fr)
ES (1) ES2214267T3 (fr)
GB (1) GB9909075D0 (fr)
HK (1) HK1045304B (fr)
HR (1) HRP20010771B1 (fr)
HU (1) HUP0200785A3 (fr)
IL (1) IL146077A0 (fr)
MA (1) MA26784A1 (fr)
MX (1) MXPA01010695A (fr)
MY (1) MY125209A (fr)
NO (1) NO320573B1 (fr)
NZ (1) NZ515164A (fr)
OA (1) OA11867A (fr)
PE (1) PE20010047A1 (fr)
PL (1) PL351115A1 (fr)
PT (1) PT1173437E (fr)
RS (1) RS50137B (fr)
SI (1) SI1173437T1 (fr)
SK (1) SK284990B6 (fr)
TR (1) TR200103041T2 (fr)
TW (1) TWI291463B (fr)
UA (1) UA72245C2 (fr)
UY (1) UY26113A1 (fr)
WO (1) WO2000063206A2 (fr)
ZA (1) ZA200108721B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
ES2278977T3 (es) * 2001-11-21 2007-08-16 Smithkline Beecham Plc Bencenosulfonato de 5-(4-(2-(n-metil-n-(2-piridil)amino)etoxi)bencil)tiazolidin-2,4-diona; procedimiento para su preparacion; polimorfos i, ii y iii de los mismos; y su uso como ingrediente activo farmaceutico.
KR100450700B1 (ko) * 2002-03-22 2004-10-01 주식회사종근당 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
US20050105328A1 (en) * 2003-11-17 2005-05-19 Ho Chiahua Perpendicular MRAM with high magnetic transition and low programming current
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP1842850A1 (fr) * 2006-03-23 2007-10-10 Sandoz AG Rosiglitazone hydrochlorid hemihydrat

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
AR023567A1 (es) 2002-09-04
NZ515164A (en) 2004-02-27
SK284990B6 (sk) 2006-04-06
ZA200108721B (en) 2002-09-13
CN101125851A (zh) 2008-02-20
PE20010047A1 (es) 2001-03-10
WO2000063206A3 (fr) 2001-02-22
TR200103041T2 (tr) 2002-03-21
DK1173437T3 (da) 2004-07-12
DZ3163A1 (fr) 2000-10-26
EG23946A (en) 2008-01-22
AP2001002332A0 (en) 2001-12-31
BG65428B1 (bg) 2008-07-31
PT1173437E (pt) 2004-06-30
NO20015105L (no) 2001-12-19
AP1680A (en) 2006-11-27
IL146077A0 (en) 2002-07-25
RS50137B (sr) 2009-03-25
SI1173437T1 (en) 2004-06-30
DE60009276T2 (de) 2004-08-26
JP4283450B2 (ja) 2009-06-24
JP2002542243A (ja) 2002-12-10
CN1327446A (zh) 2001-12-19
UY26113A1 (es) 2000-12-29
JP2009161544A (ja) 2009-07-23
KR100677815B1 (ko) 2007-02-05
EP1173437A2 (fr) 2002-01-23
HK1045304B (en) 2004-12-24
MY125209A (en) 2006-07-31
DE60009276D1 (de) 2004-04-29
AU4131100A (en) 2000-11-02
ATE262524T1 (de) 2004-04-15
BR0009898A (pt) 2002-04-16
CA2370270A1 (fr) 2000-10-26
OA11867A (en) 2006-03-02
CZ300934B6 (cs) 2009-09-16
BG106120A (en) 2002-05-31
CZ20013758A3 (cs) 2003-05-14
HRP20010771A2 (en) 2002-12-31
GB9909075D0 (en) 1999-06-16
YU81601A (sh) 2004-09-03
CO5170420A1 (es) 2002-06-27
NO320573B1 (no) 2005-12-27
TWI291463B (en) 2007-12-21
ES2214267T3 (es) 2004-09-16
EA200101102A1 (ru) 2002-04-25
UA72245C2 (uk) 2005-02-15
EP1173437B1 (fr) 2004-03-24
MXPA01010695A (es) 2002-06-04
HUP0200785A3 (en) 2004-03-29
AU773112B2 (en) 2004-05-20
SK14892001A3 (sk) 2002-02-05
NO20015105D0 (no) 2001-10-19
AR023563A1 (es) 2002-09-04
EA004769B1 (ru) 2004-08-26
PL351115A1 (en) 2003-03-24
HRP20010771B1 (en) 2005-06-30
KR20010112446A (ko) 2001-12-20
HUP0200785A2 (en) 2002-08-28
WO2000063206A2 (fr) 2000-10-26
EP1411054A1 (fr) 2004-04-21
HK1045304A1 (en) 2002-11-22

Similar Documents

Publication Publication Date Title
MA26785A1 (fr) Nouveau produit pharmaceutique.
NL1001196A1 (nl) Nieuw farmaceutisch produkt.
MA25291A1 (fr) Livraison de produits pharmaceutiques instables.
DE60034895D1 (de) Fleischemulsionsprodukt
ATE411068T1 (de) Medikamentspender
MA26937A1 (fr) Nouvelle composition pharmaceutique.
NO2013004I2 (no) Axitinib, valgfritt i form av et farmasøytisk aksentabelt salt
FR2789895B1 (fr) Produit cosmetique liquide
MA26786A1 (fr) Nouveau produit pharmaceutique.
NO20030139L (no) Farmasöytiske preparater inneholdende DDS forbindelser
DE60010089D1 (de) Beta-carbolin arzneistoffprodukte
MA25420A1 (fr) Cartouche pour produit alimentaire
EP1414495A4 (fr) Produit pharmaceutique chimerique de ciblage antimicrobien
IT1313579B1 (it) Composizione farmaceutica liquida a base di paracetamolo.
NO20014926L (no) Farmasöytiske forbindelser
EE200100445A (et) Suitsetatav toode
MA26783A1 (fr) Nouveau produit pharmaceutique
ATE289483T1 (de) Teeprodukt
DZ3163A1 (fr) Nouvelle substance pharmaceutique.
DZ2302A1 (fr) Produit pharmaceutique cristallin.
SK2926U (sk) Mäsový výrobok
MA26801A1 (fr) Complexe pharmaceutique
FR2792952B1 (fr) Nouveau produit de renforcement
DZ2159A1 (fr) Produits pharmaceutiques.
FR2791888B1 (fr) Suspension pharmaceutique buvable